Vulvar pain, itching and burning are common complaints – and often misunderstood. An estimated 10 to 28 percent of all women suffer from vulvodynia in the course of their lives; lichen sclerosus affects around 1.7 percent of the population and is up to 15 times more common than previously diagnosed. Nevertheless, it takes an average of four to seven years for a correct diagnosis to be made. The reason: the overlap between inflammatory dermatoses, functional pain syndromes and oncological precursors requires a systematic clinical assessment, which is often lacking in routine care. The new S3 guideline on lichen sclerosus and a growing body of evidence on the multimodal treatment of vulvodynia offer reliable guidance for the first time.
Autoren
- Tanja Schliebe
Publikation
- GYNÄKOLOGIE PRAXIS
Related Topics
You May Also Like
- Type 1 Diabetes: A New Disease-Modifying Treatment Approach
Slowing the loss of β-cell function and delaying the progression of the disease
- Liver Cancer
Artificial Intelligence in Precision Oncology—Opportunities and Challenges
- Acute nonspecific back pain
Implementing a biopsychosocial approach
- Psychedelic-assisted therapy
Current status of PAT
- Neuropathic Pain
Evidence-Based Neuromodulation Based on Clinical Trials and Real-World Data
- Fibromyalgia Syndrome
Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity
- Juvenile Idiopathic Arthritis
Early Detection and Targeted Treatment in an Interdisciplinary Setting
- Innovative Oral Treatment Options for Psoriasis: Icotrokinra and Zasocitinib